In cancer, the balance between pro-apoptotic and anti-apoptotic proteins is often disrupted. Overexpression of anti-apoptotic proteins like Bcl-2 and Bcl-xL is a common feature in various cancers, including lymphomas, leukemias, and solid tumors. This overexpression allows cancer cells to evade apoptosis, leading to resistance to chemotherapy and radiation therapy.
